This viewpoint assesses whether genetic testing enhances integrity in women's sports, implying significant costs for athletes.
This Viewpoint discusses whether mandatory chromosomal screening improves competitive integrity enough to justify its costs to athletes.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: